Latest in Pulmonary News

Latest in Pulmonary News2019-02-15T07:28:32-05:00

Thirty-Day Hospital Readmission Metric Linked to Increased Mortality for HF and Pneumonia

Physicians are at increased pressure to reduce readmissions for certain chronic diseases. A recent study found that implementation of the 30-day readmission rules has been associated with increased 30-day post-discharge mortality for those hospitalized for heart failure and pneumonia.

Post-discharge deaths have increased by 0.25% for patients hospitalized with heart failure and by 0.40% for patients with pneumonia since the implementation of the 30-day readmission rules.
There are approximately 8 million hospitalizations during the study period. Such small increases may account for a large number of deaths.

The findings, published online in JAMA, come from a retrospective cohort study that compared mortality rates among 8.3 million Medicare beneficiaries hospitalized for these common conditions before and after implementation of the Hospital Readmissions Reduction Program (HRRP). This early data should lead physicians to exercise caution in discharging patients prematurely.

Source: Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018;320(24):2542-2552. doi:10.1001/jama.2018.19232

Add Corticosteroids to Your Arsenal for the treatment of Inpatient Community-Acquired Pneumonia.

Corticosteroids were both beneficial and cost-effective for hospitalized adults with severe CAP. Hospitalized people with non-severe CAP may also benefit from corticosteroid therapy, but with no survival advantage

In 2015, results of two randomized trials showed that systemic corticosteroids were beneficial for some hospitalized patients with community-acquired pneumonia (CAP; NEJM JW Gen Med Mar 15 2015 and JAMA 2015; 313:677; NEJM JW Gen Med Mar 1 2015 and Lancet 2015; 385:1511). Now, two new meta-analyses — one by the Cochrane Library, and one by the Infectious Diseases Society of America (IDSA) — address whether CAP patients should receive systemic corticosteroids routinely.

These meta-analyses suggest that low-dose (≈40 mg), short-course (3–7 days) systemic corticosteroids should be strongly considered for hospitalized adults with severe CAP. These results do not apply to outpatients with CAP or to inpatients with hospital-acquired pneumonia or ventilator-associated pneumonia. Several ongoing randomized trials probably will clarify steroid use further for pneumonia indications.

Source:
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia
Chest. 2018 Nov 15. pii: S0012-3692(18)32727-2. doi: 10.1016/j.chest.2018.11.001.
https://www.ncbi.nlm.nih.gov/pubmed/30448195?dopt=Abstract

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality?

Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxemia at rest. The efficacy of oxygen therapy for breathlessness and health-related quality of life (HRQOL) in people with COPD and mild or no hypoxemia who do not meet the criteria for LTOT has not been established. Scientific evidence for its benefits of LTOT dates back to the 1980s when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT in non-COPD-patients has not been well researched and the recommendations for its application are primarily extrapolated from trials on COPD-patients.

Recent Cochrane analysis found that oxygen can relieve breathlessness when given during exercise to mildly hypoxaemic and non-hypoxaemic people with chronic obstructive pulmonary disease who would not otherwise qualify for home oxygen therapy. Findings show that COPD patients without severe hypoxemia undergoing oxygen therapy during exercise training over time do not achieve better exercise capacity or health-related quality of life compared with placebo.

However, LTOT has a beneficial effect on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia.

Source:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006429.pub3/full

J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019.
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.
https://www.ncbi.nlm.nih.gov/pubmed/30517340

Latest in Pulmonary Research

  1. Li, R, Hua, M, Li, J, Chen, W, Xu, L, Meng, H et al.. The safety of trastuzumab deruxtecan (DS-8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single-arm meta-analysis. Cancer. 2024; :. doi: 10.1002/cncr.35349. PubMed PMID:38703012 .
  2. Cao, Y, Wang, F. LncRNA RP11-773H22.4 is upregulated in severe pneumonia and may be a diagnostic and prognostic marker for severe pneumonia. Ann Biol Clin (Paris). 2024;82 (2):. doi: 10.1684/abc.2024.1886. PubMed PMID:38702934 .
  3. Yamasaki, T, Sanders, SP, Hylind, RJ, Milligan, C, Fynn-Thompson, F, Mayer, JE Jr et al.. Pathology of explanted pediatric hearts: An 11-year study. Population characteristics and implications for outcomes. Pediatr Transplant. 2024;28 (4):e14742. doi: 10.1111/petr.14742. PubMed PMID:38702926 .
  4. Shiau, BW, Hsu, WH, Tsai, YW, Wu, JY, Liu, TH, Huang, PY et al.. Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and preexisting chronic obstructive pulmonary diseases. Expert Rev Anti Infect Ther. 2024; :. doi: 10.1080/14787210.2024.2351571. PubMed PMID:38702925 .
  5. Hsu, JY, Chu, FY, Wang, PH, Wu, ML. Unusual hard metal lung disease: bronchiolocentric interstitial pneumonia. Occup Med (Lond). 2024; :. doi: 10.1093/occmed/kqae030. PubMed PMID:38702919 .
  6. Torres, MJ, Klimek, L, Agache, I, Jutel, M, Akdis, M, Shamji, MH et al.. Four years into the COVID-19 pandemic: Timely published articles for patient care and EAACI's leadership role. Allergy. 2024; :. doi: 10.1111/all.16149. PubMed PMID:38702913 .
  7. Wong, LSY, Akenroye, A, Eigenmann, P, Tham, EH. Editorial comments on "Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study". Pediatr Allergy Immunol. 2024;35 (5):e14134. doi: 10.1111/pai.14134. PubMed PMID:38702900 .
  8. De Cassai, A, Pettenuzzo, T, Busetto, V, Legnaro, C, Pretto, C, Rotondi, A et al.. Chlorhexidine is not effective at any concentration in preventing ventilator-associated pneumonia: a systematic review and network meta-analysis. J Anesth Analg Crit Care. 2024;4 (1):30. doi: 10.1186/s44158-024-00166-2. PubMed PMID:38702835 .
  9. Christensen, TD, Ording, AG, Skjøth, F, Mørkved, AL, Jakobsen, E, Meldgaard, P et al.. In-hospital thromboprophylaxis variation and the risk of venous thromboembolism after lung cancer surgery: a nationwide cohort study. Interdiscip Cardiovasc Thorac Surg. 2024; :. doi: 10.1093/icvts/ivae081. PubMed PMID:38702829 .
  10. Au-Doung, PLW, Chan, JCH, Kui, OYH, Ho, MKY, Cheung, YT, Lam, JKW et al.. Objective monitoring tools for improved management of childhood asthma. Respir Res. 2024;25 (1):194. doi: 10.1186/s12931-024-02817-y. PubMed PMID:38702779 .
  11. Pearson, A, Carrieri, D, Melvin, A, Bramwell, C, Scott, J, Hancock, J et al.. Developing a typology of interventions to support doctors' mental health and wellbeing. BMC Health Serv Res. 2024;24 (1):573. doi: 10.1186/s12913-024-10884-6. PubMed PMID:38702774 .
  12. Jimenez-Labaig, P, Aymerich, C, Braña, I, Rullan, A, Cacicedo, J, González-Torres, MÁ et al.. A comprehensive examination of mental health in patients with head and neck cancer: Systematic review and meta-analysis. JNCI Cancer Spectr. 2024; :. doi: 10.1093/jncics/pkae031. PubMed PMID:38702757 .
  13. Miles, TT, Li, SJ, Danzig, T, Marrero, M, Morales, I, Babazadeh, S et al.. Assessment of Covid-19 vaccine confidence among healthcare personnel in the safety-net sector in the United States and Puerto Rico. BMC Health Serv Res. 2024;24 (1):580. doi: 10.1186/s12913-024-10996-z. PubMed PMID:38702754 .
  14. Maggio, MC, Lembo, A, Finazzo, F, Alaimo, A, Benfratello, GF, Corsello, G et al.. Cardiovascular involvement in children with COVID-19 temporally related multisystem inflammatory syndrome (MIS-C): can cardiac magnetic resonance arrive to the heart of the problem?. Ital J Pediatr. 2024;50 (1):91. doi: 10.1186/s13052-024-01658-1. PubMed PMID:38702753 .
  15. Sharifi Aliabadi, L, Azari, M, Taherian, MR, Barkhordar, M, Abbas, SAM, Azari, M et al.. Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis. Virol J. 2024;21 (1):103. doi: 10.1186/s12985-024-02375-1. PubMed PMID:38702752 .
  16. Lin, YT, Lin, KM, Wu, KH, Lien, F. Enhancing pneumonia prognosis in the emergency department: a novel machine learning approach using complete blood count and differential leukocyte count combined with CURB-65 score. BMC Med Inform Decis Mak. 2024;24 (1):118. doi: 10.1186/s12911-024-02523-1. PubMed PMID:38702739 .
  17. Batıhan, G, Ceylan, KC, Kaya, ŞÖ. Risk factors and prognostic significance of early postoperative complications for patients who underwent pneumonectomy for lung cancer. J Cardiothorac Surg. 2024;19 (1):272. doi: 10.1186/s13019-024-02777-w. PubMed PMID:38702724 .
  18. Yang, Y, Li, J, Cheng, X, Cheng, S, Xie, X. Export priority technique for Uni-portal thoracoscopic left upper lobectomy. J Cardiothorac Surg. 2024;19 (1):275. doi: 10.1186/s13019-024-02738-3. PubMed PMID:38702716 .
  19. Wang, Y, Meng, Z, Wei, S, Li, X, Su, Z, Jiang, Y et al.. Urinary volatile organic compound metabolites and COPD among US adults: mixture, interaction and mediation analysis. Environ Health. 2024;23 (1):45. doi: 10.1186/s12940-024-01086-y. PubMed PMID:38702703 .
  20. de Mendieta, JM, Argüello, A, Menocal, MA, Rapoport, M, Albornoz, E, Más, J et al.. Emergence of NDM-producing Enterobacterales infections in companion animals from Argentina. BMC Vet Res. 2024;20 (1):174. doi: 10.1186/s12917-024-04020-z. PubMed PMID:38702700 .
  21. Eberl, M, Tanaka, LF, Kraywinkel, K, Klug, SJ. Histology-specific standardized incidence ratio improves the estimation of second primary lung cancer risk. BMC Med. 2024;22 (1):187. doi: 10.1186/s12916-024-03398-9. PubMed PMID:38702684 .
  22. Zhao, BL, Yu, FY, Zhao, ZN, Zhao, R, Wang, QQ, Yang, JQ et al.. Periodontal disease increases the severity of chronic obstructive pulmonary disease: a Mendelian randomization study. BMC Pulm Med. 2024;24 (1):220. doi: 10.1186/s12890-024-03025-6. PubMed PMID:38702679 .
  23. Lin, X, Chen, X, Chen, Y, Xu, P, Chen, S. Sleep initiation patterns and sleep quality among toddlers in the southeast of China: initial study results. BMC Pediatr. 2024;24 (1):298. doi: 10.1186/s12887-024-04786-z. PubMed PMID:38702673 .
  24. Collingridge Moore, D, Garner, A, Cotterell, N, Harding, AJE, Preston, N. Long term care facilities in England during the COVID-19 pandemic-a scoping review of guidelines, policy and recommendations. BMC Geriatr. 2024;24 (1):394. doi: 10.1186/s12877-024-04867-9. PubMed PMID:38702669 .
  25. Karki, M, El Asmar, ML, Sasco, ER, El-Osta, A. Public libraries to promote public health and wellbeing: a cross-sectional study of community-dwelling adults. BMC Public Health. 2024;24 (1):1226. doi: 10.1186/s12889-024-18535-5. PubMed PMID:38702663 .
Search PubMed

Search Terms: Asthma, COPD, Lung Cancer, Pneumonia, Pulmonary Fibrosis

Home | How We Are Different | Services | Specialist Team | Locations | Forms | Blog | Contact Us

Copyright © 2016 Allergy Sleep & Lung Care. All Rights Reserved.
This website does not contain medical advice and the use of this website does not create a physician/patient relationship between you and Allergy Sleep & Lung Care.
Terms of Use | HIPAA Privacy Policy | Sitemap | Privacy Policy

Go to Top